-+ 0.00%
-+ 0.00%
-+ 0.00%

Pharvaris reports Phase 2 CHAPTER-1 and RAPIDe-1 trial results for oral deucrictibant in hereditary angioedema

Reuters·03/20/2026 10:53:58

Please log in to view news